Reduction in phosphorylated heavy neurofilament in the cerebellum in HIV disease.

about

Loss of cerebellar neurons in the progression of lentiviral disease: effects of CNS-permeant antiretroviral therapy.

P2860

Q37340889-BFB975AB-24BF-4BB7-8FCE-1D312D2B055C

P2860

Reduction in phosphorylated heavy neurofilament in the cerebellum in HIV disease.

Item

http://www.wikidata.org/entity/Q48461014

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年学术文章

@wuu

1999年学术文章

@zh

1999年学术文章

@zh-cn

1999年学术文章

@zh-hans

1999年学术文章

@zh-my

1999年学术文章

@zh-sg

1999年學術文章

@yue

1999年學術文章

@zh-hant

name

Reduction in phosphorylated heavy neurofilament in the cerebellum in HIV disease.

@en

Reduction in phosphorylated heavy neurofilament in the cerebellum in HIV disease.

@nl

type

Item

label

Reduction in phosphorylated heavy neurofilament in the cerebellum in HIV disease.

@en

Reduction in phosphorylated heavy neurofilament in the cerebellum in HIV disease.

@nl

prefLabel

Reduction in phosphorylated heavy neurofilament in the cerebellum in HIV disease.

@en

Reduction in phosphorylated heavy neurofilament in the cerebellum in HIV disease.

@nl

P1476

Reduction in phosphorylated heavy neurofilament in the cerebellum in HIV disease.

@en

P2093

Barnes H

http://www.w3.org/2001/XMLSchema#string

Everall IP

http://www.w3.org/2001/XMLSchema#string

P2860

The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation

Flip and flop: a cell-specific functional switch in glutamate-operated channels of the CNS

Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity

HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists

MAPKs: new JNK expands the group

Neuronal number and volume alterations in the neocortex of HIV infected individuals.

The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes.

Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6

Neurofilament phosphorylation: a new look at regulation and function.

Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ.

P304

43-55

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1300/J128V02N02_05

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1999-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16873193

http://www.w3.org/2001/XMLSchema#string

P921

phosphorylation

Reduction in phosphorylated heavy neurofilament in the cerebellum in HIV disease.

about

P2860

P2860

Reduction in phosphorylated heavy neurofilament in the cerebellum in HIV disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921